Cargando…
Combining TMEM Doorway Score and Mena(Calc) Score Improves the Prediction of Distant Recurrence Risk in HR+/HER2− Breast Cancer Patients
SIMPLE SUMMARY: 90% of breast cancer mortality is caused by distant metastasis, a process that involves both dissemination of cancer cells to distant sites as well as their proliferation after arrival. However, prognostic assays currently used in the clinic are based on proliferation and do not meas...
Autores principales: | Ye, Xianjun, Oktay, Maja H., Xue, Xiaonan, Rohan, Thomas E., Ginter, Paula S., D’Alfonso, Timothy, Kornaga, Elizabeth N., Morris, Don G., Entenberg, David, Condeelis, John S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101795/ https://www.ncbi.nlm.nih.gov/pubmed/35565297 http://dx.doi.org/10.3390/cancers14092168 |
Ejemplares similares
-
Tumor Microenvironment of Metastasis (TMEM) Doorways Are Restricted to the Blood Vessel Endothelium in Both Primary Breast Cancers and Their Lymph Node Metastases
por: Ginter, Paula S., et al.
Publicado: (2019) -
Validation of an Automated Quantitative Digital Pathology Approach for Scoring TMEM: A Prognostic Biomarker for Metastasis
por: Entenberg, David, et al.
Publicado: (2020) -
Quantitative assessment of invasive mena isoforms (Mena(calc)) as an independent prognostic marker in breast cancer
por: Agarwal, Seema, et al.
Publicado: (2012) -
A metastasis biomarker (MetaSite Breast™ Score) is associated with distant recurrence in hormone receptor-positive, HER2-negative early-stage breast cancer
por: Sparano, Joseph A., et al.
Publicado: (2017) -
Mena(calc), a quantitative method of metastasis assessment, as a prognostic marker for axillary node-negative breast cancer
por: Forse, Catherine L., et al.
Publicado: (2015)